Anti-Interleukin-6 Receptor Antibody Treatment in Inflammatory Autoimmune Diseases

By  

Reviews on Recent Clinical Trials, Vol. 1, Iss. 3, 2006-09 ,pp. : 193-200

Bentham Science Publishers

Access to resources Recommend Favorite

Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy

By  

Acta Haematologica, Vol. 126, Iss. 3, 2011-07 ,pp. : 147-150

Karger

Access to resources Recommend Favorite

Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: Calprotectin and IL-6 changes do not correspond to sRAGE changes

By Malíčková Karin   Kalousová Marta   Fučíková Terezie   Bortlík Martin   Ďuricová Dana   Komárek Viktor   Zima Tomáš   Janatková Ivana   Lukáš Milan  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 70, Iss. 4, 2010-07 ,pp. : 294-299

Informa Healthcare

Access to resources Recommend Favorite

The blockade of interleukin-6 receptor as a therapeutic strategy for chronic inflammatory diseases

By Hoshino-Yoshio Naoko   Watanabe Dai   Adachi Yasuo   Nishimoto Norihiro  

Therapy, Vol. 1, Iss. 2, 2004-11 ,pp. : 267-275

Future Medicine

Access to resources Recommend Favorite

Evaluation of disease‐mediated therapeutic protein–drug interactions between an anti–interleukin‐6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 12, 2015-12 ,pp. : 1386-1394

John Wiley & Sons Inc

Access to resources Recommend Favorite